The latest report by IMARC Group, titled “Infection Surveillance Solutions Market Report by Component (Software, Services), Deployment Type (On-premises, Cloud-based), End User (Hospitals, Clinics, Ambulatory Service Centers, Specialty Centers, and Others), and Region 2024-2032“,  The global infection surveillance solutions market size reached US$ 652.6 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 1,314.8 Million by 2032, exhibiting a growth rate (CAGR) of 7.65% during 2024-2032. 

Infection surveillance solutions are advanced tools and methodologies employed by healthcare institutions and public health organizations to monitor and manage the spread of infectious diseases. These solutions play a pivotal role in maintaining the health and safety of communities by providing real-time data collection, analysis, and reporting capabilities. They enable healthcare professionals to track and identify outbreaks, monitor the prevalence of specific infections, and assess the effectiveness of interventions. By leveraging cutting-edge technology and data analytics, infection surveillance solutions empower healthcare facilities to swiftly detect and respond to potential threats, ultimately minimizing the impact of infectious diseases on both individual patients and public health at large.

For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/infection-surveillance-solutions-market/requestsample

Infection Surveillance Solutions Market Trends and Drivers:

The prevalence of healthcare-associated infections continues to be a significant concern, driving the need for advanced surveillance solutions. HAIs not only lead to patient harm but also increase healthcare costs. Additionally, events such as the COVID-19 pandemic have underscored the importance of early detection and containment of infectious diseases. This heightened awareness has led to increased investments in surveillance solutions. Other than this, healthcare providers increasingly rely on data-driven insights to improve patient outcomes. Infection surveillance solutions offer valuable data for informed decision-making. Besides this, expanding healthcare infrastructure in emerging markets, coupled with a focus on patient safety, has created new opportunities for market growth. In line with this, governments and healthcare organizations are allocating more resources to infection control as part of their commitment to improving healthcare quality.

Report Segmentation:

The report has segmented the market into the following categories:

Breakup by Component:

  • Software
  • Services

Breakup by Deployment Type:

  • On-premises
  • Cloud-based

Breakup by End User:

  • Hospitals
  • Clinics
  • Ambulatory Service Centers
  • Specialty Centers
  • Others

Market Breakup by Region:

  • North America (United States, Canada)
  • Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
  • Latin America (Brazil, Mexico, Others)
  • Middle East and Africa

Competitive Landscape with Key Player:

  • Baxter International Inc.
  • Becton Dickinson and Company
  • Centrak Inc. (Halma plc)
  • Cerner Corporation
  • CKM Healthcare Incorporated
  • Ecolab Inc.
  • International Business Machines Corporation
  • Medexter Healthcare
  • Perahealth Inc.
  • PointClickCare
  • Premier Inc.
  • Sunquest Information Systems Inc. (Roper Technologies Inc.)

Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel No:(D) +91 120 433 0800

United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163